Publications by authors named "K Haden"

Claim this Profile
P
Power outages increase the risk of ambulance attendances associated with non-optimal temperatures.
Zhihu Xu, Rongbin Xu, Gongbo Chen, Wenzhong Huang, Zhengyu Yang, Kathryn Haden

Environ Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival benefit associated with screening of patients at elevated risk for pancreatic cancer.
William J Kane, Kathleen R Haden, Elizabeth N Martin, Vanessa M Shami, Andrew Y Wang

J Surg Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64).
Rick Daniel Vavolizza, Gina R Petroni, Ileana S Mauldin, Kimberly A Chianese-Bullock, Walter C Olson, Kathleen Haden

J Immunother Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanoma.
Sapna P Patel, Gina R Petroni, Jason Roszik, Walter C Olson, Nolan A Wages, Kathleen Haden

J Immunother Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63).
Craig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, Nolan A Wages, Walter C Olson, Kathleen Haden

J Immunother Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis